2024 Annual Meeting and International Conference of the KSPST
November 26th(Tue) - 28th(Thu), 2024
The-K Hotel Seoul, Seoul, Republic of Korea
Dear all participants,
Welcome to the 2024 International Conference of the Korean Society of Pharmaceutical Sciences and Technology (KSPST)!
The conference will be held in November 26-28, 2024 in Seoul, Korea, under the theme of “Bench to bed translation in pharmaceutical science with various technologies” This conference aims to highlight recent breakthroughs and innovative achievements in pharmaceutical sciences and technology, with particular emphasis on the critical advancements and applications of diverse technologies in bridging the gap between basic research and clinical application. The scientific sessions encompass a wide range of topics, including formulation development, regulatory science, drug delivery, and pharmaceutical manufacturing technology. In addition, this conference provides a great opportunity for multi-disciplinary researchers from academia, research institute, pharmaceutical industry, and government sectors to engage in fruitful scientific discussion, fostering global collaborations and networking.
Given that science and technology are rapidly evolving to meet the clinical and industrial needs for improving human health, this conference will serve as a vital platform to explore the latest research trends and cutting-edge technologies in the pharmaceutical field. I am sure that you will have very exciting and memorable experience in this scientific event.
Once again, a warm welcome all of you to the 2024 International Conference of KSPST!
Sincerely yours,
Hyo-Kyung Han, Ph.D.
President
Korean Society of Pharmaceutical Sciences and Technology
Time | Ballroom I (Gayageum A) | Ballroom II (Gayageum B) | Lobby |
---|---|---|---|
18:00-20:00 | Welcome Reception (Invited Only) |
Time | Ballroom I (Gayageum A) | Ballroom II (Gayageum B) | Lobby |
---|---|---|---|
09:00-10:30 | Registration | ||
10:30-12:00 | Annual Members’ Meeting | Educational Session Read more | |
Sa-Won Lee (Inje University) Preparing for a career in pharma R&D: Insights into project progression and the competencies that matter |
|||
Yoon-Jee Chae(Woosuk University) Fundamental training on principles and applications of IVIVC |
|||
Sang Hwan Byun (Ubix Therapeutics) Ensuring data integrity with E-Lab Note |
|||
12:00-13:00 | Lunch | ||
13:00-14:00 | Plenary Lecture I (Gayageum A/B Hall)Read more | ||
Twan Lammers (RWTH Aachen University) Strategies to promote cancer nanomedicine performance and clinical translation |
|||
14:00-14:10 | Coffee Break | ||
14:10-16:10 | CRS Korea Chapter Joint Session Read more | Biopharmaceutics, Pharmacokinetics & Metabolism Read more | Poster Session I [15:00-18:00] Standing [16:00-17:00] |
14:10-14:50 | Paolo Caliceti (University of Padua) Tailored supramolecular architectures for biological drug delivery |
Jurgen Bulitta (University of Florida) Combating multidrug-resistant bacterial superbugs by learning how to play the penicillin-binding protein receptor piano |
|
14:50-15:30 | Yoon Yeo (Purdue University) Leveraging cancer immunotherapy by spatiotemporal control of drug delivery |
Yoshiyuki Shirasaka (Kanazawa University) Quantitative analysis of gastrointestinal drug absorption and disposition using cutting-edge technology |
|
15:30-16:10 | Xun Sun (Sichuan University) Engineered nanoemulsions modulate immune responses for treating cancer and autoimmune diseases |
Tae Hwan Kim (Daegu Catholic University) Recent strategies for anterior segment ocular drug delivery: Prolonged precorneal residence time for increasing ocular bioavailability |
|
16:10-16:20 | Coffee Break | ||
16:20-18:20 | Biotechnology & Drug Delivery I Read more | Global Pharma Session Read more | |
16:20-17:00 | Maria A. Croyle (University of Texas at Austin) Platform technologies for personalized health |
Jong Bong Lee (Novartis) Radioligand therapy: For a wider therapeutic index than antibody-drug conjugates |
|
17:00-17:40 | Sei Kwang Hahn (POSTECH) Digitally controlled smart nanomedicines |
Ryo Kojima (Astellas Pharma Inc.) Development and manufacturing of mRNA-LNP therapeutics from industry perspective |
|
17:40-18:20 | Yu Seok Youn (Sungkyunkwan University) Highly photoactive upconverting nanoparticles for enhancing chemodynamic cancer therapy |
Shantanu Damle (Colorcon Asia Pvt. Ltd.) Achieving zero-order extended drug release from lab to commercial scale |
|
18:30-20:00 | Banquet |
Time | Ballroom I (Gayageum A) | Ballroom II (Gayageum B) | Lobby |
---|---|---|---|
09:00-09:20 | Registration | Poster Session II [09:00-12:00] Standing [10:00-11:00] |
|
09:20-10:10 | KSPST Award Lectures (Gayageum A Hall)Read more | ||
10:10-12:10 | Asian Pharmaceutical Science Session Read more | JPI-AJPS Joint Session Read more | |
10:10-10:50 | Jiong-Wei Wang (National University of Singapore) Nanomedicines targeting plaque inflammation in atherosclerosis |
Cong Luo (Shenyang Pharmaceutical University / AJPS) Carrier-free small-molecule nanoassemblies for biomedical applications |
|
10:50-11:30 | Hsing-Wen Sung (National Tsing Hua University) Noninvasive gut-to-brain oral delivery systems |
Qikun Jiang (Shenyang Pharmaceutical University / AJPS) Intestinal transporter mediated innovative drugs |
|
11:30-12:10 | Fakhar-Ud-Din (Quaid-i-Azam University) Nanomedicine-based strategies for targeting tumor microenvironment: Opportunities & challenges |
Hyun-Jong Cho (Kangwon National University / JPI) Multifunctional injectable hydrogel systems for cancer therapy |
|
12:10-13:00 | Lunch | ||
13:00-14:00 | Plenary Lecture II (Gayageum A Hall) Read more | Poster Session III [13:00-16:00] Standing [14:00-15:00] |
|
Beom-Jin Lee (Ajou University) A journey from pharmaceutical excipient to fattigation in drug delivery |
|||
14:00-16:00 | Biotechnology & Drug Delivery II Read more | Pharmaceutical Industry Session Read more | |
14:00-14:40 | Sangyong Jon (KAIST) Oral anti-inflammatory nanomedicine for inflammatory bowel disease treatment |
Yong Woo Cho (ExoStemTech / Hanyang University) The challenge of translating exosomes from academia to industry |
|
14:40-15:20 | Hee Ho Park (Hanyang University) Chimeric macrophages: Cell engineering to expand their therapeutic potentials |
Youngcheol Kang (PAEAN biotechnology Inc.) MitoTherapy as a novel therapeutic strategy for mitochondrial diseases |
|
15:20-16:00 | Kayeong Lim (KIST) Precise genome engineering: from nucleus to mitochondria |
Jung Hwan Lee (Interoligo Corp.) Implantable aptamer target therapy to prevent tumor recurrence and eliminate metastases after tumor resection |
|
16:00-16:10 | Coffee Break | ||
16:10-17:40 | Pharmaceutics for Biologics Read more | Ministry of Food & Drug Safety Joint Session Read more | |
16:10-16:40 | Eun Ji Park (D&D Pharmatech) Discovery and development of novel oral GLP-1 receptor agonist |
Sang Beom Han (Chung-Ang University) Study on mitigating genotoxic impurities in pharmaceuticals |
|
16:40-17:10 | Jung-Hwan Park (Gachon University / QuadMedicine) Development and production of pharmaceutical microneedles |
Miyoung Kim (Jeil Pharmaceutical Co., Ltd.) Practical strategy to control nitrosamines and NDSRIs in pharmaceutical products |
|
17:10-17:40 | Hyun Jung Chung (KAIST) Bioorthogonal approaches in gene editing, delivery and therapy |
Kyung Hun Son(NIFDS) Guideline and practice for the safe management of impurities in pharmaceuticals |
|
17:40-17:50 | Poster / Presentation Award (Gayageum A Hall) | ||
17:50-18:00 | Closing Remark (President of KSPST; Gayageum A Hall) |
TBD | Young Scientist Session and Poster Oral Presentation (Bipa Hall) |
---|
Plenary Speaker
Strategies to promote cancer nanomedicine clinical translation
Tailored supramolecular architectures for biological drug delivery
Leveraging cancer immunotherapy by spatiotemporal control of drug delivery
Drug delivery systems for immunomodulation and gene therapy
Platform technologies for personalized health
Quantitative analysis of gastrointestinal drug absorption and disposition using cutting-edge technology
Combating multidrug-resistant bacterial superbugs by learning how to play the penicillin-binding protein receptor piano
Carrier-free small-molecule nanoassemblies for biomedical applications
Research on intestinal transporter mediated innovative drugs
Radioligand therapy: For a wider therapeutic index than antibody-drug conjugates
Achieving zero-order extended drug release from lab to commercial scale
Development and manufacturing of mRNA-LNP therapeutics from industry perspective
Noninvasive gut-to-brain oral delivery systems
Nanomedicine-based strategies for targeting tumor microenvironment: Opportunities & challenges
Nanomedicines targeting plaque inflammation in atherosclerosis
Status | Early-Bird Registration (7.15 ~ 10.10) |
Advance Registration (10.11 ~ 11.15) |
On-Site Registration (11.27 ~ 11.28) |
Banquet Ticket |
---|---|---|---|---|
General Member | 220,000 KRW | 230,000 KRW | 250,000 KRW | 20,000 KRW (200 People on a first-come, first-served basis) |
Student Member | 100,000 KRW | 110,000 KRW | 120,000 KRW | |
Non-member | 270,000 KRW | 290,000 KRW | 320,000 KRW |
Membership Status | Annual Membership Fee |
---|---|
Director (이사) | 200,000 KRW |
Lifetime Director (종신이사) | 170,000 KRW |
Committee Member (평의원) | 80,000 KRW |
Lifetime Committee Member (종신평의원) | 50,000 KRW |
General Member (일반회원) | 30,000 KRW |
Student Member (학생회원) | 10,000 KRW |
※ If there is a problem with the card payment process,
100% refund | When requesting a refund by 1 month before the event (Before October 25) |
---|---|
No refund | From 1 month before the event (October 26) ~ on the day of the event |
※ Abstract submission period: July 15 (Mon) ~ October 25 (Fri), 2024
※ Please make sure to check out!
November 27(Wed) 15:00-18:00
Standing 16:00-17:00
November 28(Thu) 09:00-12:00
Standing 10:00-11:00
November 28(Thu) 13:00-16:00
Standing 14:00-15:00
Due to the COVID-19 situation, the countries that can enter without a visa may change, so please check with the relevant authorities for details.
New Zealand, Malaysia, Japan, Chinese Taipei, Brunei, Thailand, Macau, Singapore, Hong Kong
Guyana, Brazil, Honduras, Guatemala, St. Lucia, Uruguay, Grenada, St. Vincent and the Grenadines, Jamaica, Nicaragua, Chile, República Dominicana, St. Kitts and Nevis, Canada, Commonwealth of Dominica, Suriname, Costa Rica, Mexico, Argentina, Colombia, United States, Haiti, Trinidad and Tobago, Barbados, Antigua and Barbuda, Panama, Bahamas, Ecuador, Paraguay, Venezuela, El Salvador, Peru
Vatican, Malta, Andorra, Greece, Belgium, Albania, Netherlands, Bosnia and Herzegovina, Estonia, Norway, Cyprus, Denmark, San Marino, United Kingdom, Germany, Serbia, Austria, Latvia, Bulgaria, Italy, Russia, Sweden, Switzerland, Czech Republic, Romania, Croatia, Turkey, Luxembourg, Spain, Portugal, Lithuania, Slovakia, Poland, Liechtenstein, Slovenia, France, Monaco, Iceland, Finland, Tenegro, Ireland, Hungary
Morocco, Swaziland, Liberia, Egypt, Oman, Lesotho, Mauritius, Qatar, Israel, Seychelles, Kuwait, Tunisia, Saudi Arabia, Bahrain, South Africa, United Arab Emirates
Guam, Nauru, New Caledonia, Micronesia, Solomon Islands, Kiribati, Fiji, Marshall Islands, Palau, Samoa, Australia, Tuvalu, Tonga
K-ETA is mandatory for nationals from visa-free entry countries who enter Korea without a visa. You should apply for the K-ETA at least 72 hours prior to boarding the flight bound for the Republic of Korea. You can apply for K-ETA website (www.k-eta.go.kr) or mobile app (K-ETA).
In order to request the documents required for a visa application, please register first including payment.
Address 70, Baumoe-ro 12-gil, Seocho-gu, Seoul
Tel +82-2-571-8100
Subway
Bus
Airport Bus
About KSPST
KSPST News
Publications
Conferences
Membership